Replies to post #29248 on NorthWest Biotherapeutics Inc (NWBO)

[notbrad]

Yes, I was thinking along those same lines, of a prep for label expansion. That would be super!

Regarding the lingering questions about what LP meant by "expansion", listen again to the call:
1. Minute 1:50 - "We're in the home stretch of DCVax-L phase III".
2. Followed about a minute later by "First interim analysis for efficacy expected later this year".
3. Minute 22;30 - "L will finish enrollment later this year".

Does anyone really think there will be an increase in enrollment size based on above?.

A new arm? Possible, but remote, at this late stage of the game.

A new indication for L? Possible. Here's my theory on this. They must be very confident of L for Brain. They have L for prostate sitting on the shelf for a phase III. Maybe they have found a partner. Who knows. I guess we will know in a month.